JACK E. STOVER

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

INTERPACE BIOSCIENCES, INC.

Filing Date Source Excerpt
2007-04-30 Jack E. Stover, age 54. Mr. Stover has been a director since August 2005. ... The Audit Committee is currently composed of Mr. Stover (chairperson), Mr. Sullivan and Dr. Curti. ... Jack Stover Fees earned or paid in cash ($) 62,917, Stock awards ($) 8,751, Option awards ($) 36,635, Total ($) 108,303.
2008-04-28 Jack E. Stover, age 55. Mr. Stover has been a director since August 2005. ... The Audit Committee is currently comprised of Mr. Stover (chairperson), Mr. Sullivan and Dr. Curti. ... The following table presents information relating to total compensation for our non-employee directors for the year ended December 31, 2007. ... Jack Stover 65,000 fees + 23,750 stock awards + 21,371 option awards + 792 nonqualified compensation earnings = 110,912 total.
2009-04-24 Jack E. Stover, age 56. Mr. Stover has been a director since August 2005. ... The Audit Committee is currently comprised of Mr. Stover (chairperson), Mr. Belle, Ms. Lubatkin and Mr. Sullivan. ... Jack Stover 65,000 Fees earned or paid in cash ($) 38,747 Nonqualified Compensation Earnings ($) (9,344) Total ($) 94,403
2010-04-30 Jack E. Stover, age 57. Mr. Stover has been a director since August 2005. ... The Audit Committee is currently comprised of Mr. Stover (chairperson), Mr. Belle, Ms. Lubatkin and Mr. Sullivan. ... Mr. Stover’s fees represent the annual director’s fee of $40,000 plus an additional $25,000 fee paid to Mr. Stover for his service as the chair of the Audit Committee. ... Jack Stover (2) (7) $65,000 $45,002 - $5,664 - $115,666
2011-04-28 Jack E. Stover, age 58. Mr. Stover has been a director since August 2005 and is Chairman of the Audit Committee of the Company. ... Mr. Stover’s fees represent the annual director’s fee of $40,000 plus an additional $25,000 fee paid to Mr. Stover for his service as the Chair of the Audit Committee.
2012-04-27 Jack E. Stover, who has been a director since August 2005, is Chairman of the Audit Committee of the Company. ... The Audit Committee is currently comprised of Mr. Stover (chairperson), Mr. Belle, Ms. Lubatkin and Mr. Sullivan. ... Director Compensation ... Jack Stover ... Total ($) ... 122,002.
2013-04-30 Jack Stover is Chairman of the Audit Committee. His fees represent the annual director's fee of $40,000 plus $25,000 for Chair of the Audit Committee and $12,000 for Special Advisory Committee, totaling $122,006.
2014-04-28 Jack E. Stover, who has been a director since August 2005, is Chairman of the Audit Committee of the Company. ... Mr. Stover’s fees represent the annual director’s fee of $40,000 plus an additional $25,000 fee paid to Mr. Stover for his service as the Chair of the Audit Committee. Mr. Stover also received $12,000 for his participation in the 2013 Special Advisory Committee.
2015-04-30 Jack E. Stover joined us as a director in August 2005 and is Chairman of the Audit Committee of the Company. ... Mr. Stover’s fees represent the annual director’s fee of $40,000 plus an additional $25,000 fee paid to Mr. Stover for his service as the Chair of the Audit Committee. Mr. Stover also received $12,000 for his participation in the 2014 Special Advisory Committee.
2016-06-22 Mr. Stover was appointed as President and Chief Executive Officer effective June 21, 2016. Mr. Stover has been a member of the Board since 2005 and previously served as Chairman of the Audit Committee of the Board from 2005 to December 22, 2015. Mr. Stover's fees as director from 01/01/2015-12/21/2015 were $63,234 and stock awards $45,000, total $108,234.
2017-08-14 Jack E. Stover has been a member of the Board since 2005 and previously served as Chairman of the Audit Committee of the Board from 2005 to December 22, 2015. He was appointed as President and Chief Executive Officer of the Company effective June 21, 2016. Mr. Stover has been a member of the Board of Directors, Chairman of the Audit Committee, and a member of the Compensation Committee and Special Deal Committee of Onconova Therapeutics, Inc., a publicly held biopharmaceutical company since May 2016.
2018-04-30 Information regarding the compensation of Mr. Stover can be found below, under the heading “Information About Our Executive Compensation.” Mr. Stover earned $92,000 based on 2017 performance. A reduced 30% performance bonus was proposed by Mr. Stover and subsequently approved by the Compensation Committee as his discretionary bonus. This bonus was paid in March 2018. Mr. Stover earned $937,058 as non-equity incentive compensation from multiple share offerings and warrant exercises in 2017.
2019-08-22 Jack E. Stover has been a member of the Board of the Company and its predecessor, PDI, Inc. since 2005. He was appointed as President and Chief Executive Officer of the Company effective June 21, 2016. The following table sets forth certain information concerning compensation for 2017 and 2018 paid to our Chief Executive Officer and our other two most highly compensated executive officers. Jack E. Stover: Total 2018 compensation $1,307,880.
2019-11-14 Jack E. Stover President and Chief Executive Officer Currently serves as our President and Chief Executive Officer and as a member of the Board.
2020-06-10 Jack E. Stover From December 2015 until June 2016, Mr. Stover served as Interim President and Chief Executive Officer of the Company. Mr. Stover has served on the Board since August 2005 and was chairman of the Audit Committee from August 2005 until December 2015. In June 2016, Mr. Stover was named President and Chief Executive Officer of the Company. The following table sets forth certain information concerning compensation for 2018 and 2019 paid to our Chief Executive Officer and our other two most highly compensated executive officers who served in this capacity as of December 31, 2019. Total compensation for Mr. Stover in 2019 was $862,291.

Traws Pharma, Inc.

Filing Date Source Excerpt
2016-04-13 Mr. Stover received his B.A. in Accounting from Lehigh University and is a Certified Public Accountant.
2017-04-12 Mr. Stover received his B.A. in Accounting from Lehigh University and is a Certified Public Accountant, with experience in financial operations and audit committees.
2018-02-28 Jack E. Stover(12) 3,060 * Includes 3,050 shares of common stock issuable upon the exercise of options that are currently exercisable or exercisable within sixty days of February 16, 2018.
2018-05-17 Jack E. Stover is listed as a director but no software-related skills or technical background are mentioned.
2018-06-08 Mr. Stover received his B.A. in Accounting from Lehigh University and is a Certified Public Accountant.
2019-04-29 Mr. Stover received his B.A. in Accounting from Lehigh University and is a Certified Public Accountant.
2020-04-23 Mr. Stover received his B.A. in Accounting from Lehigh University and is a Certified Public Accountant.
2021-01-13 Jack E. Stover(7) Includes 11,965 shares of common stock issuable upon the exercise of options that are currently exercisable or exercisable within sixty days of the record date.
2021-05-28 Mr. Stover was also formerly a partner with PricewaterhouseCoopers (then Coopers and Lybrand), working in the bioscience industry division in New Jersey. Mr. Stover received his B.A. in Accounting from Lehigh University and is a Certified Public Accountant.
2022-05-25 Mr. Stover received his B.A. in Accounting from Lehigh University and is a Certified Public Accountant.
2023-06-07 Mr. Stover received his B.A. in Accounting from Lehigh University and is a Certified Public Accountant.
2024-08-09 Jack E. Stover remained on the Board of Directors.
2024-10-11 Mr. Stover received his B.A. in Accounting from Lehigh University and is a Certified Public Accountant. He has senior leadership experience in the life sciences industry and has served as chairman of audit committees.
2025-02-06 Jack E. Stover, listed as a director with no mention of software or technical skills.

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-22